Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood FlowCaroline J. Breitbach, John C. Bell, J. Andrea McCart et al.|Molecular Therapy|2007Cited by 277
Identification of Genetically Modified Maraba Virus as an Oncolytic RhabdovirusJ Brun, David F. Stojdl, Dan C. McManus et al.|Molecular Therapy|2010Cited by 158
Synergistic Interaction Between Oncolytic Viruses Augments Tumor KillingJohn C. Bell, Jean‐Simon Diallo, J. Andrea McCart et al.|Molecular Therapy|2010Cited by 132
VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus InfectionRozanne Arulanandam, John C. Bell, Cory Batenchuk et al.|Cancer Cell|2015Cited by 104
Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus MacaquesLaura Evgin, J. Andrea McCart, Sergio A. Acuña et al.|Molecular Therapy|2015Cited by 80